GenesisPlus uses Cutera’s patented microsecond technology and has a proprietary delivery system with a temperature sensor which aids to improve practitioner and patient experience.
The laser systyem is also used to treat wrinkles, vascular lesions, pigmented lesions, warts and accelerates scar remodeling, including surgical, hypertrophic and keloid scars.
Cutera president and CEO Kevin Connors said they are pleased that, with the recent Health Canada approval, GenesisPlus is now available to physicians throughout US, Canada and Europe.
